When evaluating potential agencies, consider their expertise in various aspects of branding and design.
The FTC Wrongly Blames PBMs for High Drug Prices
Putting the customer at the core of your product development ensures relevance and resonance.
The 340B Drug Discount Program Needs an Overhaul
CAGW has long been concerned with the misuse of the 340B Program.
Eastern Tennessee: Where Broadband Goes Bust
Government-owned broadband networks have failed across the country, but public utilities in Tennessee want to build them anyway.
A Disturbing Trend for Broadband Deployment
With $42.5 billion available for broadband deployment, funding should be available regardless of technology or vendor type.
Congress Should not Double Down on Devastating Drug Price Controls
House Democrats’ new bill on price controls will devastate future drug development and raise costs.
Estimates of COVID-19 Relief Fraud Continue to Increase
The government’s failure to distribute relief money correctly continues to be unearthed.
GAO Duplication Report Offers Roadmap to Cut Government Waste
The GAO offers commonsense ways to reduce duplicative and wasteful spending.
House Appropriators Incorporate Many of CAGW’s Prime Cuts Recommendations
The House Appropriations Committee passed a bill that includes many of CAGW’s Prime Cuts recommendations.
Nevada Falls for the Stadium Subsidy Scam
The new ballpark for the Athletics is sure to cost taxpayers for years to come, with little tangible gains in return.